Consolidated Planning Corp increased its holdings in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 11.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 35,760 shares of the company’s stock after acquiring an additional 3,535 shares during the period. Consolidated Planning Corp’s holdings in Procter & Gamble were worth $6,094,000 at the end of the most recent reporting period.
Several other hedge funds have also recently bought and sold shares of PG. Norges Bank purchased a new stake in Procter & Gamble in the 4th quarter worth about $5,244,463,000. GAMMA Investing LLC lifted its stake in Procter & Gamble by 20,758.5% in the 1st quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company’s stock worth $1,355,087,000 after acquiring an additional 7,913,335 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in Procter & Gamble in the 4th quarter worth about $1,010,685,000. Bank Julius Baer & Co. Ltd Zurich lifted its stake in Procter & Gamble by 1,195.1% in the 4th quarter. Bank Julius Baer & Co. Ltd Zurich now owns 3,222,585 shares of the company’s stock worth $580,596,000 after acquiring an additional 2,973,757 shares in the last quarter. Finally, Capital Research Global Investors increased its position in Procter & Gamble by 62.5% in the 4th quarter. Capital Research Global Investors now owns 7,398,120 shares of the company’s stock worth $1,240,294,000 after purchasing an additional 2,846,560 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.
Procter & Gamble Price Performance
Shares of NYSE:PG opened at $161.11 on Tuesday. The business has a 50 day moving average price of $163.19 and a 200 day moving average price of $165.91. Procter & Gamble Company has a twelve month low of $156.58 and a twelve month high of $180.43. The company has a market cap of $377.73 billion, a price-to-earnings ratio of 25.57, a PEG ratio of 4.69 and a beta of 0.43. The company has a quick ratio of 0.50, a current ratio of 0.71 and a debt-to-equity ratio of 0.47.
Procter & Gamble Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Investors of record on Monday, April 21st were paid a dividend of $1.0568 per share. This is an increase from Procter & Gamble’s previous quarterly dividend of $1.01. The ex-dividend date was Monday, April 21st. This represents a $4.23 annualized dividend and a yield of 2.62%. Procter & Gamble’s dividend payout ratio is presently 67.14%.
Insider Activity at Procter & Gamble
In other Procter & Gamble news, insider Moses Victor Javier Aguilar sold 10,520 shares of the firm’s stock in a transaction that occurred on Monday, May 5th. The stock was sold at an average price of $158.67, for a total value of $1,669,208.40. Following the completion of the sale, the insider now owns 25,182 shares in the company, valued at approximately $3,995,627.94. This trade represents a 29.47% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Jennifer L. Davis sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total value of $161,380.00. Following the completion of the sale, the chief executive officer now owns 51,965 shares of the company’s stock, valued at $8,386,111.70. This represents a 1.89% decrease in their position. The disclosure for this sale can be found here. 0.18% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
PG has been the topic of several research reports. Truist Financial dropped their target price on Procter & Gamble from $185.00 to $180.00 and set a “buy” rating on the stock in a research report on Friday, April 25th. Royal Bank Of Canada raised Procter & Gamble from a “sector perform” rating to an “outperform” rating and upped their target price for the stock from $164.00 to $177.00 in a research report on Friday, April 25th. Evercore ISI reaffirmed an “outperform” rating and issued a $190.00 target price (up from $170.00) on shares of Procter & Gamble in a research report on Tuesday, June 3rd. Piper Sandler upped their target price on Procter & Gamble from $160.00 to $164.00 and gave the stock a “neutral” rating in a research report on Monday, May 5th. Finally, Barclays reaffirmed an “equal weight” rating on shares of Procter & Gamble in a research report on Thursday, March 27th. Eight research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $178.86.
Read Our Latest Stock Analysis on Procter & Gamble
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More
- Five stocks we like better than Procter & Gamble
- Investing In Automotive Stocks
- Microsoft Stock Holds Steady as AI Drives Workforce Shift
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- D-Wave Goes International With South Korea Partnership
- What is the FTSE 100 index?
- Payment Giants Slide on Stablecoin Buzz—Is Now the Time to Buy?
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.